In this paper we characterize, classify and axiomatize all universal classes of MV-chains. Moreover, we accomplish analogous characterization, classification and axiomatization for congruence distributive quasivarieties of MV-algebras. Finally, we apply those results to study some finitary extension
Ultraproducts of Z with an Application to Many-Valued Logics
✍ Scribed by Joan Gispert i Brasó; Daniele Mundici; Antoni Torrens Torrell
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 140 KB
- Volume
- 219
- Category
- Article
- ISSN
- 0021-8693
No coin nor oath required. For personal study only.
✦ Synopsis
Up to categorical equivalence, abelian lattice-ordered groups with strong unit coincide with Chang's MV-algebrasᎏthe Lindenbaum algebras of the infinite-valued Łukasiewicz calculus. While the property of being a strong unit is not definable even in first-order logic, MV-algebras form an equational class. On the other hand, the addition operation and the translation invariant lattice order of a lattice-ordered group are more amenable than the truncated addition operation of an MV-algebra. In this paper MV-algebraic and group-theoretical techniques are combined to classify and axiomatize all universal classes generated by an infinite totally ordered * Partially supported by Grants Nos. FIr94-1351 and SGRr96-00052 of DGR of Generalitat de Catalunya and by Grant No. PB97-0888 of DGICYT of Spain and by COST ACTION 15 on many-valued logics for computer science applications.
📜 SIMILAR VOLUMES
## Abstract It is known (see Rapp [9]) that elementary geometry with the additional quantifier “there exist uncountably many” is decidable. We show that this decidability helps in solving the following problem from combinatorial geometry: does there exist an uncountable family of pairwise non‐congr
## Abstract Here, we describe an automated nonparametric method for evaluating gadolinium‐diethylene triamine pentaacetic acid (Gd‐DTPA) kinetics, based on dynamic contrast‐enhanced–MRI scans of glioblastoma patients taken before and after treatment with bevacizumab; no specific model or equation s